Journal of Hematology Oncology Pharmacy

Time 2021-11-12 08:07:02

Web Name: Journal of Hematology Oncology Pharmacy

WebSite: http://jhoponline.com

ID:229276

Keywords:

of,Journal,Hematology,Pharmacy,Oncology,

Description:

keywords:
description:
Home Issues 2021 October 2021 Vol 11, No 5 August 2021 Vol 11, No 4 June 2021 Vol 11, No 3 April 2021 Vol 11, No 2 March 2021 Vol 11 Special Feature February 2021 Vol 11, No 1 2020 December 2020, Vol 10, No 6 October 2020, Vol 10, No 5 August 2020, Vol 10, No 4 June 2020, Vol 10, No 3 April 2020 Vol 10, No 2 February 2020 Vol 10, No 1 Issue Archive Online First Special Issues Supplements Guide to New FDA Approvals Categories Conference Correspondent AACR ASCO 2021 - Midyear Review ASCO 2021 Breast Cancer Highlights ASCO Highlights ASH Highlights ESMO Highlights SABCS Highlights Web Exclusives All Web Exclusives Interview with the Innovators FDA Approvals Videos Press Releases Lung Cancer Monthly Minutes Gastrointestinal Cancer Monthly Minutes Melanoma Monthly Minutes For Authors Author Guidelines Symptom Management Overview Guidelines Letters to the Editor Instructions Peer Review Application Submit a Manuscript About About JHOP About GreenhillHC Contact Us Editorial Policies Peer-Review Process About the Editors Editorial Board Editorial Process Advertising Contacts Advertising Policy Advertise Subscribe Sign Up Now! To sign up for our newsletter or print publications, please enter your contact information below. Featured Articles Outcomes of Pharmacist-Provided Telehealth Services in an Ambulatory Oncology Clinic During the COVID-19 PandemicColleen Bohnenkamp, PharmD, BCOP, BCPS, Grace A. Martin, PharmD, BCOP, Laure DuBois, PharmD, BCOP, Olivia Fahey, PharmD, BCOP, Jade Hefler, PharmDRead MoreSuccessful Treatment of Nivolumab plus Ipilimumab–Mediated Pure Red-Cell Aplasia and Diabetes with CyclosporineParikshit Padhi, MD, MBBS, Traci M. White, PharmD, PhC, BCGP, Neslihan Cetin, MDRead MoreTolerance of Oral Targeted Therapies in Patients with Metastatic Renal-Cell Carcinoma and Renal ImpairmentJessica McKernan, PharmD, BCOP, Laura Schmidt, PharmD, BCOP, Melissa Rhoades, PharmD, BCOPRead MoreRecent Targeted Therapies Approved for the Treatment of Patients with Urothelial CarcinomaBojana Stevich-Heemer, MS, PharmD, MEd, BCOPRead MoreUrine Alkalinization and Methotrexate Clearance: Are These Key to Safe Administration of High-Dose Methotrexate?Joseph Bubalo, PharmD, BCPS, BCOPRead MoreEfficacy of an Enteral Urine Alkalinization Strategy During Intravenous Sodium Bicarbonate Shortage in Patients with Cancer Receiving High-Dose MethotrexateChristopher Sinoimeri, PharmD, Matthew Lei, PharmD, BCOP, Stephanie Monaco, PharmD, BCOP, Uvette Lou, PharmD, BCOPRead More From the Literature Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70Read MoreAdjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal CancerRead MoreNew Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in AmericaRead MoreLow-Dose Capecitabine Maintenance Therapy Improves Survival in Patients with Triple-Negative Breast CancerRobert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPARead MoreEnfortumab Vedotin Superior to Chemotherapy in Urothelial CancerRobert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPARead MoreOral Azacitidine Prolongs Survival in Patients with Acute Myeloid LeukemiaRobert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPARead More FDA Updates Tivdak First Antibody–Drug Conjugate FDA Approved for Recurrent or Metastatic Cervical CancerRead More Exkivity Novel Oral Targeted Therapy Approved for Metastatic NSCLC with EGFR Exon 20 Insertion MutationsRead MoreWelireg FDA Approved for 3 Tumor Types Associated with von Hippel-Lindau DiseaseRead MoreRezurock Novel Oral Therapy FDA Approved for Chronic Graft-Versus-Host DiseaseRead MoreJakafi a New Treatment Option for Chronic Graft-Versus-Host DiseaseRead MoreCabometyx Receives FDA Approval for Differentiated Thyroid CancerRead More Meeting Highlights Atezolizumab, Vemurafenib, and Cobimetinib Triplet Therapy Improves PFS in BRAF-Positive MelanomaRead MoreTwo Ways to Target Tumors with KRAS MutationsRead MoreTargeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene MutationsRead MoreCeritinib Effective in Treating Brain Metastases in NSCLCRead MoreParadigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian CancerRead MoreAdding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of CareRead More


Privacy policy Terms of Use Home About Subscribe Advertise Contact Us Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.

TAGS:of Journal Hematology Pharmacy Oncology 

<<< Thank you for your visit >>>

Hot Websites